Science|Business is canvassing views on the big research priorities for the next term of the EU, from 2019 to 2024. Here, six policy experts discuss the most pressing items on the EU’s to-do list for health

New report shows how long term investment in novel products like cell and gene therapies is beginning to bear fruit. The concern now is the price of these products and ensuring patients get access

In medical image analysis, AI can surpass human experts; in diabetes it can raise an alarm in time to head off a glycaemic event. Hints of its power, but concerns about privacy are slowing deployment of AI tools

At a Science|Business event in Norway, students, technology experts and teachers debated the merits of new breeds of healthcare delivery. There are benefits, but digital health must be thoughtfully controlled and users properly trained

Commission underestimated difficulties of deploying EU-wide eHealth system, which has seen little exchange of information to date

In a final interview as European Patients Forum secretary general, Nicola Bedlington says the EU needs a ‘home for health’ in the European Commission, and patients should be at the centre of designing new health research initiatives

Armed with bear spray, microbiologist Naowarat ‘Ann’ Cheeptham is searching for hardy, less-studied bacteria that could play a role in stemming the antimicrobial resistance crisis